Mass Tort brief
States Target Corporate Asset Shields as Water and Talc Settlements Advance
Sixteen states sue to block Corteva's PFAS spinoff while courts advance $149 million in foam settlements and weigh Camp Lejeune frameworks.
Mass Tort
Sixteen states moved to block Corteva's Vylor spinoff — challenging corporate restructurings designed to insulate profitable seed assets from billions in PFAS liabilities.
BackgroundChemical manufacturers face tens of billions of dollars in environmental cleanup lawsuits and health claims over toxic per- and polyfluoroalkyl substances, or PFAS. Corporate spinoffs have increasingly drawn legal challenges from state attorneys general who allege reorganizations are designed to strand liabilities in undercapitalized legacy entities.
- State attorneys general filed in Indiana court immediately after Corteva finalized separating its Pioneer seed and agricultural genetics business into standalone entity Vylor.
- The complaint asserts the restructuring leaves legacy chemical units unable to satisfy anticipated drinking-water decontamination and remediation judgments across dozens of states.
- The coalition requested an immediate preliminary injunction freezing transferred assets, seeking joint liability guarantees from newly created operating subsidiaries before capital is distributed.
Mass Tort
Split verdicts in Massachusetts and Louisiana demonstrated lingering talc trial risks — keeping pressure on J&J to secure its $5.5B settlement framework.
BackgroundTens of thousands of plaintiffs claim cosmetic talcum powder products were tainted with asbestos fibers that caused fatal mesothelioma and ovarian cancers. J&J withdrew talc products from global markets while maintaining its formulations were safe and pursuing a comprehensive global resolution.
- A Massachusetts jury cleared J&J of causation liability, finding that while warning labels were inadequate, the product did not cause the plaintiff's mesothelioma.
- Simultaneously, a Louisiana state court jury awarded $10 million to a victim's family, finding J&J and corporate co-defendants liable for failure to warn.
- The contrasting jury outcomes land as J&J solicits votes to surpass the 95% claimant threshold required to implement its $5.5 billion ovarian cancer settlement framework.
Mass Tort
The AFFF court published $149M in utility settlements — clearing municipal contamination claims ahead of high-stakes personal injury cancer trials.
BackgroundAqueous film-forming foam used for decades at military airfields and commercial airports contaminated municipal groundwater across the country with carcinogenic fluorinated chemicals. Thousands of public water providers and individual cancer victims consolidated claims in South Carolina federal court to coordinate pretrial discovery.
- The proposed agreements resolve water provider contamination liabilities for Carrier Global ($129.2M), Archroma U.S. ($14M), Amerex ($4M), and Nation Ford Chemical ($1.875M).
- U.S. District Judge Richard Gergel set a final approval hearing for January 15, 2027, allowing public water utilities time to submit filtration infrastructure claims.
- The multidistrict court is concurrently completing bellwether discovery on drinking-water kidney and testicular cancer claims, setting up the litigation's first personal injury trials.
Mass Tort
Federal judges extended Camp Lejeune leadership counsel through 2027 — using weekly settlement master oversight to force progress on a global compensation deal.
BackgroundThe Camp Lejeune Justice Act allows military veterans and family members exposed to contaminated drinking water at the North Carolina base between 1953 and 1987 to sue the federal government. Hundreds of thousands of claims have overwhelmed the federal judicial docket in the Eastern District of North Carolina.
- The judicial panel mandated weekly conferences with settlement masters, warning leadership counsel that concrete progress toward a comprehensive global resolution framework remains mandatory.
- The Department of Justice has issued over $1.1 billion in settlement offers under the administrative process, aiming to resolve undisputed cancer claims without trial.
- The first federal bench trials addressing disputed kidney cancer claims remain scheduled for November 2026 before U.S. District Judge Terrence Boyle.
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
